Drug Marketed in Asia Even After Toxicity Occurs in Similar Drug Ketek

October 27th, 2008 | Category: General Health

According to news reports a new drug known as cethromycin, part of the ketolide drug class, will start being marketed in Asia even though a similar medicine known as Ketek, from the same drug

class, raised serious red flags among physicians and drug regulators when the antibiotic was linked to severe liver toxicity among patients leading to several fatalities.

Original post by articles@legalview.com (Katie Kelley)

Share and Enjoy: These icons link to social bookmarking sites where readers can share and discover new web pages.